Is GGAMF or MRK a better dividend investment in 2026?

GGAMF currently yields 508.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: GGAMF offers higher current income.

What is the dividend yield difference between GGAMF and MRK?

GGAMF has a forward dividend yield of 508.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 505.24 percentage points.

Home › Compare › GGAMF vs MRK

GGAMF vs MRK: Dividend Comparison 2026

GGAMF yields 508.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GGAMF wins by $69434.48M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GGAMF

● Live price

508.00%

Share price

$0.39

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$69434.54M

Annual income

$50,052,515,220.85

Full GGAMF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — GGAMF vs MRK

📍 GGAMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GGAMF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GGAMF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GGAMF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GGAMF

Annual income on $10K today (after 15% tax)

$43,180.09/yr

After 10yr DRIP, annual income (after tax)

$42,544,637,937.72/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, GGAMF beats the other by $42,544,629,609.31/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GGAMF + MRK for your $10,000?

GGAMF: 50%MRK: 50%

100% MRK50/50100% GGAMF

Portfolio after 10yr

$34717.30M

Annual income

$25,026,262,509.49/yr

Blended yield

72.09%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GGAMF

No analyst data

Altman Z

-3638.6

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GGAMF buys

MRK buys

No recent congressional trades found for GGAMF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGGAMFMRK

Forward yield	508.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$69434.54M ✓	$56.8K
Annual income after 10y	$50,052,515,220.85 ✓	$9,798.13
Total dividends collected	$67756.12M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: GGAMF vs MRK ($10,000, DRIP)

Year	GGAMF Portfolio	GGAMF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$61,500	$50,800.10	$11,206	$366.19	+$50.3K → GGAMF
2	$357,787	$291,982.37	$12,650	$502.35	+$345.1K → GGAMF
3	$1,970,363	$1,587,530.83	$14,407	$694.19	+$1.96M → GGAMF
4	$10,278,995	$8,170,706.09	$16,585	$967.82	+$10.26M → GGAMF
5	$50,834,928	$39,836,403.59	$19,342	$1,363.89	+$50.82M → GGAMF
6	$238,516,316	$184,122,942.57	$22,913	$1,947.19	+$238.49M → GGAMF
7	$1,062,596,213	$807,383,755.41	$27,662	$2,823.89	+$1062.57M → GGAMF
8	$4,498,580,780	$3,361,602,832.28	$34,159	$4,173.35	+$4498.55M → GGAMF
9	$18,114,040,093	$13,300,558,658.12	$43,337	$6,308.80	+$18114.00M → GGAMF
10	$69,434,538,121	$50,052,515,220.85	$56,776	$9,798.13	+$69434.48M → GGAMF

GGAMF vs MRK: Complete Analysis 2026

GGAMF — Stock

Good Gamer Entertainment Inc. operates as a e-sports, skills-based, and real-money gaming tournament management platform in Canada and the United States. The company operates through Display Advertisements, Tournament Management Platform (TMP), Non-Fungible Tokens (NFTs) and Corporate and Development segments. It operates an online esports skills-based real-money gaming tournament management platform allows game developers to enhance unity-based mobile games, enabling real money social competition in their games and allowing the game developers to host casual esports tournaments for mobile players to win real money prizes. The company also creates and develops Chosen Ones non-fungible tokens (NFTs); artwork, characters, and a play-to-earn NFT-based blockchain game; and data management platform, a software platform used for collecting and managing data. Good Gamer Entertainment Inc. is headquartered in Vancouver, Canada.

Full GGAMF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this GGAMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GGAMF vs SCHD GGAMF vs JEPI GGAMF vs O GGAMF vs KO GGAMF vs MAIN GGAMF vs JNJ GGAMF vs ABBV GGAMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.